YOSHIZAWA Hirohisa 吉澤弘久

Researcher Number	50282984
Other IDs
Affiliation (based on the past Project Information) *help	2014 – 2017: 新潟大学, 医歯学総合病院, 特任教授 2014: 新潟大学, 医歯学総合病院, 教授 2007 – 2013: Niigata University, Medical and Dental Hospital, Associate Professor 2008: 新潟大学, 医歯学総合病, 准教授 2005 – 2006: 新潟大学, 医歯学総合病院, 助教授 2004: 新潟大学, 大学院・医歯学総合研究科, 講師
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine Except Principal Investigator Respiratory organ internal medicine / 膠原病・アレルギー・感染症内科学
Keywords	Principal Investigator 肺癌 / 制御性T細胞 / DR5 / CD40 / CD137 / 抗サイトカイン抗体 / 抗VEGF抗体 / 健常者 / 担癌患者 / 術後再発 … More / 末梢血循環腫瘍細胞 / Lung cancer / EGFR-TKI / MDSCs / Predictive factor / Regulatory T細胞 / αGalCel / 樹状細胞 / 皮下腫瘍モデル / CD62 / 抗CD40抗体 / 防御免疫 / RNA導入 / Dendritic cell … More Except Principal Investigator 肺線維症 / 呼吸器感染症 / その他 / 制御性T細胞 / 小細胞肺癌 / 抑制性T細胞 / 腫瘍免疫療法 / regulatory T cell / lymphodepletion / 外科的肺生検 / 凝固線溶系 / 間質性肺炎 / 気管支肺胞洗浄 / TAT(thrombin antithrombin複合体) / D-dimer / 気管支肺胞洗浄液 / TAT / トロンビン / Tissue Factor / PAI-1 / protease activated receptor-1 / 自己抗体 / サイトカイン / GM-CSF / TNF-α / インターロイキン / VEGF / 非閉塞性肺疾患 / Th17 / 非閉塞性肺疾患癌 / 非特異的肺疾患癌 / 化学療法 / MDSC / 抗腫瘍免疫療法 / 放射線療法 / Tumor immunotherapy / Regulatory T cells / lung cancer / 腫瘍免疫 / 肺癌 / 細胞療法 / tumor immunotherapy / regulatory T cells / 抗腫瘍エフェクターCD4 T細胞 / 抗腫瘍エフェクターCD4T細胞 / small cell lung cancer / antitumor effector CD4 T cell / 免疫療法 / PD-1 / T細胞 / PD-L1 / Adoptive immunotherapy / adoptive immunotherapy Less

Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancer
- Principal Investigator
  
  Watanabe Satoshi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Search of the effect predictive factor in molecules target therapy for lung cancerPrincipal Investigator
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunity
- Principal Investigator
  
  WATANABE Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Development of system to predict postoperative recurrence of lung cancer/order-made treatment using peripheral blood circukationg tumor cellPrincipal Investigator
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Effective cancer immunotherapy for advanced lung cancer during homeostatic proliferation
- Principal Investigator
  
  WATANABE Satoshi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Antitumor immunotherapy for small cell lung cancer with Th17 induction
- Principal Investigator
  
  KAGAMU Hiroshi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Treatment of lung cancer with the regulation of anti-VEGF auto-antibodyPrincipal Investigator
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Blood coaguration and fibrinolytic pathways may connect with acute exacerbation of interstitial pneumonia
- Principal Investigator
  
  TERADA Masaki
- Project Period (FY)
  2006 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
感染・炎症における生体の恒常性維持に関する新概念の確立
- Principal Investigator
  
  NAKATA Koh
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  膠原病・アレルギー・感染症内科学
- Research Institution
  Niigata University
A novel antitumor immunotherapy to break the tolerance induced in small cell lung cancer patients
- Principal Investigator
  
  KAGAMU Hiroshi
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Application of allograft rejection for lung cancer treatmentPrincipal Investigator
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University

All 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004

All Journal Article Presentation Book

[Book] 呼吸器研修ノート2011
- Author(s)
  吉澤弘久
- Total Pages
  840
- Publisher
  診断と治療社
- Data Source
  KAKENHI-PROJECT-21590983
[Book] 肺癌診療Q&A2011
- Author(s)
  吉澤弘久
- Total Pages
  343
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-21590983
[Book] 病態の仕組みがわかる免疫学担当部分抗腫瘍免疫2010
- Author(s)
  吉澤弘久, 他
- Total Pages
  9
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-21590983
[Book] IV期非小細胞肺癌に対する初回化学療法2009
- Author(s)
  吉澤弘久
- Total Pages
  9
- Publisher
  科学評論社
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer2018
- Author(s)
  Kondo Rie、Watanabe Satoshi、Shoji Satoshi、Ichikawa Kosuke、Abe Tetsuya、Baba Junko、Tanaka Junta、Tsukada Hiroki、Terada Masaki、Sato Kazuhiro、Maruyama Yoshie、Makino Masato、Hirata Akira、Tanaka Hiroshi、Koya Toshiyuki、Yoshizawa Hirohisa、Kikuchi Toshiaki
- Journal Title
  
  Oncology
  
  Volume: 94 Pages: 223-232
- DOI
  10.1159/000486622
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-18KT0019
[Journal Article] Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.2016
- Author(s)
  Ko Sato, Satoshi Watanabe,corresponding author Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, and Ichiei Narita
- Journal Title
  
  BMC Cancer
  
  Volume: 16(1) Pages: 222-222
- DOI
  10.1186/s12885-016-2271-8
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25860637, KAKENHI-PROJECT-26293196, KAKENHI-PROJECT-15K09168
[Journal Article] Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation2015
- Author(s)
  Fukuhara T, Yoshizawa H et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 88 Pages: 181-186
- DOI
  10.1016/j.lungcan.2015.02.004
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25461172, KAKENHI-PROJECT-26461175, KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-15K15320
[Journal Article] Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.2015
- Author(s)
  Saida Y, Watanabe S, Tanaka T, Baba J, Sato K, Shoji S, Igarashi N, Kondo R, Okajima M, Koshio J, Ichikawa K, Nozaki K, Ishikawa D, Koya T, Miura S, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I
- Journal Title
  
  Journal of immunology
  
  Volume: 195 Pages: 726-735
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Journal Article] Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.2014
- Author(s)
  Watanabe S, Yoshizawa H et al.
- Journal Title
  
  J Thorac Oncol.
  
  Volume: 11 Pages: 189-94
- DOI
  10.1097/jto.0000000000000048
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25461172
[Journal Article] DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.2014
- Author(s)
  Nozaki K, Yoshizawa H et al.
- Journal Title
  
  PloS one
  
  Volume: 9
- DOI
  10.1371/journal.pone.0111019
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-26293196
[Journal Article] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.2013
- Author(s)
  Koshio, J. Kagamu, H. Nozaki, K. Saida, Y. Tanaka, T. Shoji, S. Igarashi, N. Miura, S. Okajima, M. Watanabe, S. Yoshizawa, H. Narita, I.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 62 Pages: 1619-1628
- DOI
  10.1007/s00262-013-1467-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591141, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25860637
[Journal Article] Updated Overall Survival Results from A Randomized Phase III Trial Comparing Gefitinib with Carboplatin-Paclitaxel for Chemo-Naïve Non-Small Cell Lung Cancer with Sensitive EGFR Gene Mutations (NEJ002).2013
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, et al
- Journal Title
  
  Ann Oncol.
  
  Volume: 24 Pages: 54-59
- DOI
  10.1093/annonc/mds214
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-23591132, KAKENHI-PROJECT-24240042, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF2013
- Author(s)
  Ishikawa D, Yano S, et al.
- Journal Title
  
  Plos One
  
  Volume: 8
- DOI
  10.1371/journal.pone.0062104
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22112010, KAKENHI-PROJECT-23591141, KAKENHI-PROJECT-24300329, KAKENHI-PROJECT-24390209, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25860638, KAKENHI-PROJECT-25860640
[Journal Article] The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy.2013
- Author(s)
  Miura S, Watanabe S, Sato K, Makino M, Kobayashi O, Miyao H, Iwashima A, Okajima M, Tanaka J, Tanaka H, Kagamu H, Yokoyama A, Narita I, Yoshizawa H.
- Journal Title
  
  Support Care Cancer. 2013
  
  Volume: 21 Pages: 2575-2581
- DOI
  10.1007/s00520-013-1835-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25860637
[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia2012
- Author(s)
  Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I.
- Journal Title
  
  Blood
  
  Volume: 12 Pages: 2417-2427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591156
[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.2012
- Author(s)
  Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I.
- Journal Title
  
  Blood
  
  Volume: 120 Pages: 2417-2427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.2012
- Author(s)
  Ichikawa, K., Kagamu, H., Koyama, K., Miyabayashi, T., Koshio, J., Miura, S., Watanabe, S., Yoshizawa, H. and Narita, I.
- Journal Title
  
  Vaccine
  
  Volume: 30 Pages: 6190-6197
- DOI
  10.1016/j.vaccine.2012.07.060
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591141, KAKENHI-PROJECT-24591156
[Journal Article] Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial2012
- Author(s)
  Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.
- Journal Title
  
  Oncologist
  
  Volume: 17 Pages: 863-70
- DOI
  10.1634/theoncologist.2011-0426
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591006, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.2012
- Author(s)
  Ichikawa K, Kagamu H, Koyama K, Miyabayashi T, Koshio J, Miura S, Watanabe S, Yoshizawa H, Narita I.
- Journal Title
  
  Vaccine
  
  Volume: 30 Pages: 6190-6197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] 肺癌治療薬2011
- Author(s)
  吉澤弘久
- Journal Title
  
  医薬ジャーナル
  
  Volume: 47 Pages: 180-4
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations2011
- Author(s)
  吉澤弘久(他9名9番目)
- Journal Title
  
  J Thorac Oncol
  
  Pages: 1413-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Groth Factor Receptor Mutations.2011
- Author(s)
  Satoh H, Yoshizawa H et al.
- Journal Title
  
  J Thorac Oncol.
  
  Volume: 8 Pages: 1413-7
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations2011
- Author(s)
  Satoh H, Yoshizawa H, et al.
- Journal Title
  
  J Thorac Oncol
  
  Volume: 8 Pages: 1413-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor2011
- Author(s)
  宮林貴大、各務博、渡部聡、吉澤弘久、成田一衛
- Journal Title
  
  Cancer Immunol Immunother
  
  Pages: 1597-608
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] 肺癌化学療法時の悪心・嘔吐の実際2011
- Author(s)
  田中洋史、吉澤弘久, 他
- Journal Title
  
  臨床腫瘍プラクティス
  
  Volume: 7 Pages: 329-36
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor2011
- Author(s)
  Miyabayashi T, Yoshizawa H, et al
- Journal Title
  
  Cancer immunology immunotherapy
  
  Volume: 11 Pages: 1597-1608
- DOI
  10.1007/s00262-011-1063-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983, KAKENHI-PROJECT-21590984, KAKENHI-PROJECT-23591141
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy : a retrospective analysis2011
- Author(s)
  渡部聡、田中純太、太田毅、近藤利恵、田中洋史、各務博、市川紘将、古塩純、馬場順子、宮林貴大、成田一衛、吉澤弘久
- Journal Title
  
  BMC Cancer
  
  Pages: 1-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatmentin non-small cell lung cancer patients who benefited from prioreffective gefitinib therapy a retrospective analysis.2011
- Author(s)
  渡部聡、田中純太、太田毅、近藤利恵、田中洋史、各務博、市川紘将、古塩純、馬場順子、宮林貴大、成田一衛、吉澤弘久
- Journal Title
  
  BMC Cancer
  
  Volume: 11 Pages: 1-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy : a retrospective analysis2011
- Author(s)
  Watanabe S, Yoshizawa H, et al
- Journal Title
  
  BMC Cancer
  
  Volume: 11 Pages: 1-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] enoch Schonlein purpura associated with pulmonary adenocarcinoma2011
- Author(s)
  Mifune D, Yoshizawa H, et al
- Journal Title
  
  J Med Case Reports
  
  Volume: 1 Pages: 226-8
- DOI
  10.1186/1752-1947-5-226
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated mantiumor reactivity against parental tumor.2011
- Author(s)
  Miyabayashi T, Yoshizawa H et al.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 11 Pages: 1597-608
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] A phase III open-label of palonosetron for preventing chemothrapy-induced mausea and vomiting(CINV) in repeated cycled of emetogenic chemotherapt.2011
- Author(s)
  Aogi K, Yoshizawa H et al.
- Journal Title
  
  Support Care Cancer.
  
  Volume: 34 Pages: 276-82
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Henoch Schonlein purpura associated with pulmonary adenocarcinoma.2011
- Author(s)
  Mifune D, Yoshizawa H et al.
- Journal Title
  
  J Med Case Reports.
  
  Volume: 1 Pages: 226-8
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-indue ed nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy2011
- Author(s)
  Aogi K, Yoshizawa H, et al.
- Journal Title
  
  Support Care Cancer
  
  Volume: 34 Pages: 276-82
- DOI
  10.1007/s00520-011-1239-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules2010
- Author(s)
  Takeda K, Yoshizawa H, et al
- Journal Title
  
  J Immunol
  
  Volume: 184 Pages: 5493-501
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Gefitinib or Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR2010
- Author(s)
  Maemondo M, Yoshizawa H, et al
- Journal Title
  
  N Eng J Med
  
  Volume: 362 Pages: 2380-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009
- Author(s)
  Hayashi, Y., H.Kuriyama, H.Umezu, J.Tanaka, T.Yoshimasu, T.Furukawa, H.Tanaka, H.Kagamu, F.Gejyo, H.Yoshizawa.
- Journal Title
  
  Intern Med 48
  
  Pages: 203-208
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.2009
- Author(s)
  Yoshiki Hayashi, Hideyuki Kuriyama, Hiroshi Umezu, Junta Tanaka, T. Yoshimasu, T. Furukawa, Hiroshi Tanaka, Hiroshi Kagamu, Fumitake Gejyo, Hirohisa Yoshizawa.
- Journal Title
  
  Internal medicine 48
  
  Pages: 203-208
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer2009
- Author(s)
  各務博、吉澤弘久(他8名10番目)
- Pages
  203-8
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy : a double-blind, double-dummy, randomised, comparative phase III trial2009
- Author(s)
  Saito M, Aogi K, Sekine I, Yoshizawa H, et al.
- Journal Title
  
  Lancet Oncol 10
  
  Pages: 115-124
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Class III beta-Tubulin Expression in Tumor Cells is Correlated with Resistance to Docetaxel in Patients with Completely Resected Non-Small-Cell Lung Cancer2009
- Author(s)
  Hayashi Y, Yoshizawa H. et.al.
- Journal Title
  
  Intern Med 48
  
  Pages: 203-8
- NAID
  130000122350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy : a double-blind, double-dummy, randomised2009
- Author(s)
  Saito M, Yoshizawa H et.al.
- Journal Title
  
  comparative phase III trial. Lancet Oncol 10
  
  Pages: 115-24
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity.2008
- Author(s)
  Satoru Miura, Hiroshi KagamuHiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Gejyo
- Journal Title
  
  Scandinavian journal of immunology. 67
  
  Pages: 385-391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyper responsiveness2008
- Author(s)
  Hirahara K, Yoshizawa H et.al.
- Journal Title
  
  J Allergy Clin Immunol 122
  
  Pages: 512-20
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage2008
- Author(s)
  Koyama K, Yoshizawa H et.al.
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6770-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Appropriate timing of CD40 ligation for RNA-pulsed DCs to induce antitumor immunity2008
- Author(s)
  Satoshi, Miura, Hiroshi, Kagamu, Hiroshi, Tanaka, Hirohisa, Yoshizawa, Fumitake, Gejyo
- Journal Title
  
  Scandinavian Journal of Immunology 67
  
  Pages: 385-391
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Reciprocal CD4^+ T-cell balance of effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ regulatory T cells in small cell lung cancer reflects disease stage.2008
- Author(s)
  Koyama, K., H.Kagamu, S.Miura, T.Hiura, T.Miyabayashi, R.Itoh, H. Kuriyama, H.Tanaka, J.Tanaka, H.Yoshizawa, K. Nakata, F.Gejyo
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6770-6779
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Appropriate timing of CD40 ligation for RNA-pulsed DCs to induce antitumor immunity2008
- Author(s)
  Satoshi Miura, Hiroshi Kagamu, Hiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Gejyo
- Journal Title
  
  Scandinavian Journal of Immunology 67
  
  Pages: 385-391
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity2008
- Author(s)
  Miura S, Yoshizawa H et.al.
- Journal Title
  
  Scand J Immunol 67
  
  Pages: 385-91
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Reciprocal CD4^+ T-Cell Balance of Effector CD62L^<low> CD4^+ and CD62L^<high>CD25^+ CD4^+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage.2008
- Author(s)
  Kenichi Koyama, Hiroshi Kagamu, Satoru Miura, Toru Hiura, Takao Miyabayashi, Ryo Itoh, Hideyuki Kuriyama, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Fumitake Gejyo
- Journal Title
  
  Clin Cancer Res 14
  
  Pages: 6770-6779
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.2008
- Author(s)
  Miura, S., H.Kagamu, H.Tanaka, H.Yoshizawa, F.Gejyo.
- Journal Title
  
  Scand J Immunol 67
  
  Pages: 385-391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590915
[Journal Article] Paraneoplastic neurological syndrome and polyglandular autoimmune syndrome type 2 in a case of small cell lung cancer2008
- Author(s)
  Watanabe S, Yoshizawa H. et.al.
- Journal Title
  
  Thorax 63
  
  Pages: 1118-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Generation of anti-tumor effector T cells from naive T cells by stimulation with dendritic/tumor fusion cells.2007
- Author(s)
  Akira Ishida, Hiroshi Tanaka, Toru Hiura, Satoshi Miura, Satoshi Watanabe, Koki Matsuyama, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Kagamu, Fumitake Gejyo, Hirohisa Yoshizawa
- Journal Title
  
  Scandinavian Journal of Immunology 66
  
  Pages: 546-554
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Anti-cytokine autoantibodies are ubiquitous in healthy individuals2007
- Author(s)
  Masato, Watanabe., Kanji, Uchida., Kazuhide. Nakagaki., Hiroko. Kanazawa., Bruce C, Trapnell., Yoshihiko. Hoshino, Hiroshi. Kagamu, Hirohisa. Yoshizawa, Naoto. Keicho, Hajime. Goto, Koh. Nakata
- Journal Title
  
  FEBS letters 581
  
  Pages: 2017-2021
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Generation of Anti-tumour Effector T Cells from Naive T Cells by Stimulation with Dendritic/tumour Fusion Cells2007
- Author(s)
  Ishida A, Yoshizawa H et.al.
- Journal Title
  
  Scand J Immunol 66
  
  Pages: 546-54
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Anti-cytokine autoantibodies are ubiquitous in healthy individuals2007
- Author(s)
  Masato Watanabe, Kanji Uchida, Kazuhide Nakagaki, Hiroko Kanazawa, Bruce C. Trapnell, Yoshihiko Hoshino, Hiroshi Kagamu, Hirohisa Yoshizawa, Naoto Keicho, Hajime Goto, Koh Nakata
- Journal Title
  
  FEBS letters 581
  
  Pages: 2017-2021
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Generation of anti-tumor effector T cells from naive T cells by stimulation with dendritic/tumor fusion cells2007
- Author(s)
  Akira, Ishida, Hiroshi, Tanaka, Toru, Hiura, Satoshi, Miura, Satoshi, Watanabe, Koki, Matsuyama, Hideyuki, Kuriyama, Junta, Tanaka, Hiroshi, Kagamu, Fumitake, Geiyo, Hirohisa, Yoshizawa
- Journal Title
  
  Scandinavian Journal of Immunology 66
  
  Pages: 546-554
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Anti-cytokine autoantibodies are ubiquitous in healthy individuals.2007
- Author(s)
  Watanabe M, Uchida K, Yoshizawa h, et. al.
- Journal Title
  
  FEBS Lett 581
  
  Pages: 2017-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Anti-cytokine autoantibodies are ubiquitous in healthy individuals2007
- Author(s)
  Watanabe M, Yoshizawa H, Nakata K et.al.
- Journal Title
  
  FEBS Lett 581
  
  Pages: 2017-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy2007
- Author(s)
  Shimohata T, Yoshizawa H et.al.
- Journal Title
  
  Arch Neurol 64
  
  Pages: 856-61
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Generation of anti-tumor effctor T cells from naive T cells by stimulation with dendritic/tumor fusion cells.2007
- Author(s)
  Akira Ishida, Hiroshi Tanaka, Toru Hiura, Satoshi Miura, Satoshi Watanabe, Koki Matsuyama, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Kagamu, Fumitake Gejyo, Hirohisa Yoshizawa
- Journal Title
  
  Scandinavian Journal of Immunology 66
  
  Pages: 546-554
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18590841
[Journal Article] Generation of Anti-tumour Effector T Cells from Naive T Cells by Stimulation with Dendritic/tumour Fusion Cells.2007
- Author(s)
  Ishida A, Tanaka H, Yoshizawa H, et. al.
- Journal Title
  
  Scand J Immunol 66
  
  Pages: 546-54
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngea1 findings in multiple system atrophy.2007
- Author(s)
  Shimohata T, Shinoda H, Yoshizawa h, et. al.
- Journal Title
  
  Arch Neurol 64
  
  Pages: 856-61
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590886
[Journal Article] Anti-cytokine autoantibodies are ubiquitous in healthy individuals.2007
- Author(s)
  Watanabe M, Uchida K, Nakagaki K, Kanazawa H, Trapnell B. C., Hoshino Y, Kagamu H, Yoshizawa H, Keicho N, Goto H, and Nakata K.
- Journal Title
  
  FEBS Letters 581(10)
  
  Pages: 2017-2021
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18659291
[Journal Article] Eradication of established tumors in mice by a rationally combined antibody-based therapy2006
- Author(s)
  Uno, T., T.Takeda, Y.Kojima, H.Yoshizawa et al.
- Journal Title
  
  Nature Medicine 12
  
  Pages: 693-698
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Eradication of established tumors in mice by a rationally combined antibody-based therapy2006
- Author(s)
  Uno, T., T.Takeda, Y.Kojima, H.Yoshizawa, H.et al.
- Journal Title
  
  Nature Medicine 12
  
  Pages: 693-698
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] 両側下肺野胸膜直下優位に多発性浸潤影を認めた一例2006
- Author(s)
  吉澤弘久, 高田俊範, 森山寛史, 寺田正樹鈴木栄一, 下条文武
- Journal Title
  
  内科専門医会誌 18・2
  
  Pages: 423-423
- Data Source
  KAKENHI-PROJECT-18590840
[Journal Article] Eradication of established tumors in mice by a rationally combined antibody-based therapy2006
- Author(s)
  Uno, T., T.Takeda Y.Kojima H.Yoshizawa, H.et al.
- Journal Title
  
  Nature Medicine 12
  
  Pages: 693-698
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression.2005
- Author(s)
  Hiura, T., Kagamu, H., Miura, S., Ishida, A., Tanaka, H., Tanaka, J., Gejyo, F., Yoshizawa, H.
- Journal Title
  
  Journal of Immunology 175
  
  Pages: 5058-5066
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Gender diffrences in susceptibility of asthma to active smoking.2005
- Author(s)
  Satoh, H., H.Yoshizawa, et al.
- Journal Title
  
  Allergollogy International 54
  
  Pages: 401-410
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Gender diffrences in susceptibility of asthma to active smoking.2005
- Author(s)
  Satoh, H., T.Hasegawa, E.Suzuki, M.Terada, H.Nakayama, S.Toyabe, K.Akazawa, A.Kondo, M.Arakawa, H.Yoshizawa, F.Gejyo.
- Journal Title
  
  Allergollogy International 54
  
  Pages: 401-410
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan.2005
- Author(s)
  Yoshimine, F., H.Yoshizawa et al.
- Journal Title
  
  Respirology 10
  
  Pages: 477-484
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Facial axis angle as a risk factor for obstructive sleep apnea.2005
- Author(s)
  Kubota, Y., H.Nakayama, T.Takada, N.Matsuyama, K.Sakai, H.Yoshizawa, M.Nakamata, M.Satoh, K.Akazawa, E.Suzuki, F.Gejyo.
- Journal Title
  
  Internal Medicine 44
  
  Pages: 805-810
- NAID
  130000076340
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression.2005
- Author(s)
  Hiura, T., Yoshizawa.H.et al.
- Journal Title
  
  Journal of Immunology 175
  
  Pages: 5058-5066
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Facial axis angle as a risk factor for obstructive sleep apnea.2005
- Author(s)
  Kubota, Y., H.Yoshizawa, et al.
- Journal Title
  
  Internal Medicine 44
  
  Pages: 805-810
- NAID
  130000076340
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan.2005
- Author(s)
  Yoshimine, F., T.Hasegawa, E.Suzuki, M.Terada, T.Koya, A.Kondoh, M.Arakawa, H.Yoshizawa, F.Gejyo.
- Journal Title
  
  Respirology 10
  
  Pages: 477-484
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Questionnaire-based characterization of bronchial asthma in the elderly : Analysis in Niigata Prefecture, Japan.2004
- Author(s)
  Hasegawa, T., H.Yoshizawa, et al.
- Journal Title
  
  Allergology International 53
  
  Pages: 145-151
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.2004
- Author(s)
  Kinebuchi, S., H.Yoshizawa, et al.
- Journal Title
  
  Clinical Science (Lond) 107
  
  Pages: 317-322
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] 2004. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.2004
- Author(s)
  Kinebuchi, S., J.J.Kazama, M.Satoh, K.Sakai, H.Nakayama, H.Yoshizawa, I.Narita, E.Suzuki, F.Gejyo.
- Journal Title
  
  Clinical Science (Lond) 107
  
  Pages: 317-322
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Journal Article] 2004. Questionnaire-based characterization of bronchial asthma in the elderly : Analysis in Niigata Prefecture, Japan.2004
- Author(s)
  Hasegawa, T., E.Suzuki, Y.Muramatsu, T.Koya, I.Mashima, A.Kondo, H.Takagi, K.Fujimori, M.Arakawa, H.Yoshizawa, F.Gejyo.
- Journal Title
  
  Allergology International 53
  
  Pages: 145-151
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16590741
[Presentation] Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies2016
- Author(s)
  Miho Takahashi, Satoshi Watanabe, Ko Sato, Tomohiro Tanaka, Yu Saida, Junko Baba, Aya Ohtsubo, Miyuki Sato, Rie Kondo, Masaaki Okajima, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Toshiaki Kikuchi
- Organizer
  Annual meeting of american association for cancer research
- Place of Presentation
  New Orleans (アメリカ合衆国)
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation2015
- Author(s)
  Ko Sato, Satoshi Watanabe, Yu Saida, Tomohiro Tanaka, Junko Baba, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  Annual meeting of american association for cancer research
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Gefitinib for non-small cell lung cancer (NSCLC) with minor EGFR mutations: A retrospective study from the North East Japan Study Group (NEJ)2012
- Author(s)
  Watanabe S, Yoshizawa H. et al.
- Organizer
  2012 ESMO Congress
- Place of Presentation
  ウイーン、オーストリア
- Data Source
  KAKENHI-PROJECT-24591156
[Presentation] The efficacy of triplet antiemetic therapy for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy: palonosetron (PALO), aprepitant (APR), and dexamethasone (DEX)2012
- Author(s)
  Yoshizawa H. et al.
- Organizer
  2012 ESMO Congress
- Place of Presentation
  ウイーン、オーストリア
- Data Source
  KAKENHI-PROJECT-24591156
[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy : a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells2012
- Author(s)
  才田優、渡部聡、田中知宏、馬場順子、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  American assocation of cancer research
- Place of Presentation
  Chicago, USA
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked plays an oncogenic roles to induce cancer stem cell-like properties2012
- Author(s)
  Nozaki K, Kagamu H,Yoshizawa H. et al.
- Organizer
  2012 ESMO Congress
- Place of Presentation
  ウイーン、オーストリア
- Data Source
  KAKENHI-PROJECT-24591156
[Presentation] Combination of cyclophosphamide and inhibition of chemo-resistant　suppressor cells successfully treated advanced tumors.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  日本癌学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Rondomized phase II study of concurrent gefitinib plus chemotherapy versus alteration of gefitinib and chemotherapy in previously untreated non small cell lung cancer with sensitive EGFR-mutations:NEJ 005/TCOG 09022012
- Author(s)
  Oizumi S ,Yoshizawa H. et al.
- Organizer
  第10回臨床腫瘍学会学術総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-24591156
[Presentation] Efficacy outcome in first-ling treatment of advanced NSCLC with gefitinib VS carboplatin/paclitaxel by epidermal frowth factor receptor(EGFR)-gene-copy number score and by most commo EGFR mutation.2011
- Author(s)
  Yang J, Yoshizawa H et al.
- Organizer
  European Society for Medical Onocology.
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy.2011
- Author(s)
  Watanabe S, Yoshizawa H, et al.
- Organizer
  Lung cancer Early and Metastatic. European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naive mice augment antitumor response2011
- Author(s)
  馬場順子、渡部聡、古塩純、市川紘将、田中洋史、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association for cancer research
- Place of Presentation
  オーランド(招待講演)
- Year and Date
  2011-04-04
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] DEAD/H(Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+Tumour-specific Protein and Induces Antitumour Immunity.2011
- Author(s)
  Ichikawa K, Yoshizawa H, et al.
- Organizer
  Europena Scoiety for Medical Onocology.
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naive mice augments antitumor response2011
- Author(s)
  馬場順子、渡部聡、才田優、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] DEAD/H (Asp- Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+Tumour-specific Protein and Induces Antitumour Immunity2011
- Author(s)
  Ichikawa K, Yoshizawa H, et al.
- Organizer
  European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy. Lung cancer Early and Metastatic2011
- Author(s)
  Watanabe S, Yoshizawa H, et al.
- Organizer
  European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Efficacy outcome in first-line treatment of advanced NSCLC with gefitinib VS carboplat in/paclitaxel by epidermal growth factor receptor (EGFR)-gene -copy number score and by most common EGFR mutation2011
- Author(s)
  Yang J, Yoshizawa H, et al.
- Organizer
  European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Conditioning for cancer immunotherapy ; ex vivo expanded T cells effectively develop into effectors in lymphopenic hosts2011
- Author(s)
  才田優、渡部聡、馬場順子、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] QOL Analysis from NEJ002 Study Comparing Gefitinib to Chemotherapy for Non-Small Cell Lung Cancer with Mutated EGFR2010
- Author(s)
  Yoshizawa H, et al
- Organizer
  European Society of Medical Oncology Congress
- Place of Presentation
  Milan, Italy
- Year and Date
  2010-10-10
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity.2010
- Author(s)
  古塩純、各務博、市川紘将、馬場順子、宮林貴大、渡部聡、田中洋史、田中純太、吉澤弘久、中田光、成田一衛
- Organizer
  日本癌学会学術総会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation2010
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Regulatory T cells resistant to cytotoxic regimens prevent antitumor immunity during T cell homeostatic proliferation2010
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Cancer stem cells express specific immunogenic proteins that induce Th17-dominant immunity resulting in regression of parental tumor in vivo.2010
- Author(s)
  Takao Miyabayashi, Hiroshi Kagamu, Jun Koshio, Kosuke Ichikawa, Junko Baba, Satoshi Watanabe, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Koh Nakata, Ichiei Narita
- Organizer
  American Association for Cancer Research annual meeting
- Place of Presentation
  Washington DC
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Depletion of radio-resistant peripheral regulatory T cells enhances the antitumor immune response during homeostatic proliferation2009
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Cancer stem cell targeted immunotherapy mediates potent antitumor reactivity against established parental melanoma2009
- Author(s)
  宮林貴大、吉澤弘久, 他
- Organizer
  日本癌学会総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Cancer stem cell targeted immunotherapy mediates potent antitumor reactivity against established parental melanoma.2009
- Author(s)
  宮林貴大、各務博、小山建一、馬場順子、渡部聡、田中純太、田中洋史、吉澤弘久、中田光、成田一衛
- Organizer
  日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜(intemational session)
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is a CD133^+ tumor-specific protein and induces antitumor immunity.2009
- Author(s)
  宮林貴大, 各務博, 小山建一, 栗山英之, 田中純太, 田中洋史, 吉澤弘久, 中田光, 下条文武
- Organizer
  ECCO 15-34^<th> ESMO Multidisciplinary Congress
- Place of Presentation
  Berlin
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] 癌幹細胞根絶をめざした抗腫瘍免疫療法2008
- Author(s)
  宮林貴大, 吉澤弘久, 他
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-19590886
[Presentation] Immunotherapy to eliminate cancer stem cells(癌幹細胞根絶をめざした抗腫瘍免疫療法)2008
- Author(s)
  Takao Miyabayashi, Hiroshi Kagamu. Kenichi Koyama, Takeshi Ota, Hideyuki Kuriyama, Junta Tanaka, Hiroshi Tanaka, Hirohisa Yoshizawa, Fumitake Geiyo
- Organizer
  日本癌学会
- Place of Presentation
  パシフイコ横浜
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] Immunotherapy to eliminate cancer stem cells2008
- Author(s)
  宮林貴大、各務博、小山建一、太田毅、栗山英之、田中純太、田中洋史、吉澤弘久、下条文武
- Organizer
  日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(oral session)
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-20590915
[Presentation] OVA peptideresponsive CD4 effector T cells can induce antitumor immunity via epitope spreading mediated by dendritic cells2007
- Author(s)
  Koyama K, Yoshizawa H et.al.
- Organizer
  98th Annual Meeting, American Association for Cancer Research
- Place of Presentation
  ロサンゼルス・カリフォルニア
- Year and Date
  2007-04-14
- Data Source
  KAKENHI-PROJECT-19590886
[Presentation] OVA peptide-responsive CD4 effector T cells can induce antitumor immunity via epitope spreading mediated by dendritic cells2007
- Author(s)
  Koyama K, Yoshizawa H, et. al.
- Organizer
  98th Annual Meeting, American Association for Cancer Research
- Place of Presentation
  ロサンゼルス、カリフォルニア、
- Year and Date
  2007-04-14
- Data Source
  KAKENHI-PROJECT-19590886

1. NAKATA Koh (80207802)

# of Collaborated Projects: 9 results

# of Collaborated Products: 14 results
2. KAGAMU Hiroshi (30418686)

# of Collaborated Projects: 8 results

# of Collaborated Products: 45 results
3. WATANABE Satoshi (50529740)

# of Collaborated Projects: 5 results

# of Collaborated Products: 28 results
4. TANAKA Hiroshi (80463991)

# of Collaborated Projects: 2 results

# of Collaborated Products: 12 results
5. MIURA Satoru (70420320)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
6. TERADA Masaki (50401740)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. SUZUKI Eiichi (30187710)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. HASEGAWA Takashi (90361906)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. TAKADA Toshinori (40361919)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 塚田弘樹 (50323986)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 田中純太

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. GENMA Akihiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
13. OIZUMI Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. YAMADA Tadaaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. TAKEUCHI Shinji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. 岡島正明

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
17. 木下一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
18. 前門戸任

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
19. 西條康夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
20. 井上彰

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
21. 鈴木栄一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 矢野聖二

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. 松本邦夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 中村隆弘

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 菊地利明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 阿部貴志

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

YOSHIZAWA Hirohisa 吉澤 弘久

Research Projects

Research Products

Co-Researchers

Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Search of the effect predictive factor in molecules target therapy for lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunity

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of system to predict postoperative recurrence of lung cancer/order-made treatment using peripheral blood circukationg tumor cellPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effective cancer immunotherapy for advanced lung cancer during homeostatic proliferation

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Antitumor immunotherapy for small cell lung cancer with Th17 induction

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Treatment of lung cancer with the regulation of anti-VEGF auto-antibodyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Blood coaguration and fibrinolytic pathways may connect with acute exacerbation of interstitial pneumonia

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

感染・炎症における生体の恒常性維持に関する新概念の確立

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A novel antitumor immunotherapy to break the tolerance induced in small cell lung cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Application of allograft rejection for lung cancer treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 呼吸器研修ノート2011

Author(s)

Total Pages

Publisher

Data Source

[Book] 肺癌診療Q&A2011

Author(s)

Total Pages

Publisher

Data Source

YOSHIZAWA Hirohisa 吉澤弘久